To print this page properly - use Print icon located on the page.
Please note that JavaScript has to be enabled.
Untitled-1.png

Publications des membres

Si vous êtes membre de l’ACPG et que vous souhaitez intégrer vos publications à notre liste, veuillez nous contacter à info@cagp.ca

Allard J, Hottin P , Préville M , Directeurs de publication , Volume des actes : Vieillissement et problèmes de santé mentale , Edisem , 2004.

Amyot A. , Psychothérapies de la personne âgée. Actes du congrès scientifique « Vieillissement et problèmes de santé », les 6-7-8 novembre 2003, Institut universitaire de gériatrie de Sherbrooke, Sherbrooke, 2003.

Amyot A. , Le travail du transfert et du contre-transfert dans le traitement des personnes âgées vu sous l'angle du sentiment d'inutilité In : NPG – Neurologie-Psychiatrie-Gériatrie, année 3, janvier-février 2003, no. 13, pp.53-56. 10 Congrès de l'international Psychogeriatric Association – IPA «Psychanalyse, psychothérapie et vieillissement», à Nice, septembre 2001.

Amyot A. , Hommage à Louis Guerette. Prisme, No. 41, 2003, p.164

Amyot A. , Dernier hommage à Frédéric Grunberg. In: Le journal de l'AMPQ, vol. 7, no. 7, novembre 2003, p.18.

Amyot A ., Transference and counter-transference in the treatment of elderly patients. In: The Official Journal of the International Psychogeriatric Association, vol. 13 supplement 2, September 2001. Tenth Congress of the International Psychogeriatric Association, September 9-14, 2001, Nice, France, p. 52.

Ancill, ERJ , Holliday, SG, Rabheru, K and Thorpe, L - Editors, Dementia: Cognition and Beyond, 2000 Canadian Academic Press.

Ashe, P. Chlan-Fourney, J., Juorio, A.V. and Li, X.-M . (2002). Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Brain Res 956:126-35.

Bai, O., Chlan-Fourney, J., Bowen, R., Keegan, D. and Li, X.-M . (2003). Expression of BDNF mRNA in rat hippocampus after Treatment with antipsychotic drugs. J Neurosci Res 71:127-131 .

Bai, O., Zhang, H. and Li, X.-M . (2004). Antipsychotic drugs clozapine and olanzapine upregulate bcl-2 mRNA and protein in rat frontal cortex and hippocampus. Brain Res , 1010:81-86.

Bai, O., Wei, Z., Lu, W., Bowen, R., Keegan, D. and Li, X.-M . (2002). The protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal. J Neurosci Res 69:278-283.

Browne A., Blake M., Donnelly M ., Herbert D On Liberty for the Old”. Canadian Journal of Aging (2002) 21(2):283-293

Busto, U.E., Sproule, B.A., Knight, K. Herrmann, N .: Use ofprescription and non-prescription hypnotics in a Canadian elderlypopulation. Canadian Journal of Clinical Pharmacology, 8: 213-221, 2001.

Chlan-Fourney, J., Ashe, P. Nylen, K., Juorio, A.V. and Li, X.-M . (2002). Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration. Brain Res 954:11-20.

Chen C-Y, Donnelly M “A Comparison of the Canadian and Taiwan Longterm Care Systems” The News of the Gerontological Society of Taiwan , 2002;47:6-12

Chimich, W . T., & Nekolaichuk, C. L. (2004). Exploring the links between depression, integrity, and hope in the elderly. Canadian Journal of Psychiatry, 49(7), 428-433.

Cohen, C.A. , Caregivers for People with Dementia: What is the Family Physicians Role? Canadian Family Physician 46: 376-380. (2000)

Cohen, C.A ., Pringle, D., LeDuc, L. Dementia Caregiving: The Role of the Primary Care Physician. Canadian Journal of Neurological Sciences 28 (supplemental): 572-576. (2001)

Cohen, C.A. , Colantonio, A., Verinch, L. (2001). Positive Aspects of Caregiving: Rounding Out the Caregiver Experience. International Journal of Geriatric Psychiatry (in press).

Colantonio, A., Cohen, C.A ., Pon, M. Assessing Support Needs of Caregivers of Persons with Dementia. Community Mental Health Journal 37(3): 231-243. (2001)

Cole MG , Elie LM, McCusker J, Bellavance F, Mansour A. Feasibility and effectiveness of treatments for post-stroke depression in elderly inpatients: systematic review. J Geriatr Psychiatry Neurol. 2001 Spring; 14(1): 37-41.

Cole MG , Elie LM, McCusker J, Bellavance F, Mansour A. Feasibility and effectiveness of treatments for depression in elderly medical inpatients: a systematic review. Int Psychogeriatr. 2000 Dec;12(4):453-61.

Conn DK , Clarke D, Van Reekum R . Depression in holocaust survivors: profile and treatment outcome in a geriatric day hospital program. Int. J Geriatr Psychiatry. 2000 Apr;15(4):331-7.

Conn DK, Lieff S. Diagnosing and managing delirium in the elderly. Can Fam Physician. 2001 Jan;47:101-8.

Conn, D.K. , Herrmann, N., Kaye, A., Rewilak, D., Schogt, B. (Eds.) Practical Psychiatry in the Long-Term Care Facility: A Handbook for Staff. Hogrefe and Huber: Seattle, 2001.

COSID Investigators, Sambrook, R., Herrmann, N ., Hebert, R., McCraken, P., Robillard, A., Luong, D., Yu, A.:  Canadian Outcomes Study in dementia (COSID): study methods and patient characteristics.  Canadian Journal of Psychiatry 49:417-427, 2004.

Cui, S.S., Yang, C.P., Bowen, R.C., Bai, O., Li, X.M ., Jiang, W. & Zhang, W. (2003). Valproic acid enhances axonal regeneration and recovery of motor function after sciatic nerve axotomy in adult rats. Brain Res 975:229-36.

DeCoteau W, Thorpe L . Prevention. Chapter in Treating Dementia: Cognitionand Beyond, Edited by RJ Ancill, SG Holliday, K Rabheru, and L Thorpe , 2000 Canadian Academic Press.

Donnelly ML , Jamieson JL, Brett-Maclean P, Berkowitz J. "Involving Family Physicians inCommunity Geriatrics Research: Priorities, Opportunities and Challenges". Geriatrics Today: J Can Geriatri Soc 2003; 6:161-166

Donnelly ML , Jamieson JL, Brett-Maclean P, Berkowitz J. “Geriatrics Continuing Medical Education Interest among Primary Care Physicians in B.C.” Geriatrics Today: J Can Geriatri Soc 2004;7;1:15-20

Donnelly M , Jamieson J, Brett-Maclean P. “Primary Care Geriatrics in British Columbia” Geriatrics Today: Journal of the Canadian Geriatrics Society ; (2002) 5(4):175-178

Donnelly M ., MacCourt P., "Guidelines for Elderly Mental Health Care Planning for Best Practices for Health Authorities" (Co-Chairs), Ministry of Health Services of British Columbia, Victoria, Province of British Columbia (2002)

Donnelly M., “Electroconvulsive Therapy: Guidelines for Health Authorities in British Columbia” B.C. Ministry of Health Services and the Mental Health Evaluation & Community Consultation Unit (Mheccu). (Chair, ECT Advisory Committee) (2002).

Guest Editor: M.L. Donnelly ‘The State of Seniors' Health in British Columbia” Visions: BC's Mental Health Journal ; (2002) 15(Summer):4-5

Elie M, Rousseau F, Cole M , Primeau F, McCusker J, Bellavance F. Prevalence and detection of delirium in elderly emergency department patients. CMAJ. 2000 Oct 17;163(8):977-81.

E lliott JA, Jamieson J, Donnelly ML , Malone M. ‘Measurement Properties of a New Falls Risk Self-Assessment Questionnaire for Seniors' Geriatrics Today : J Can Geriari Soc 2004;7 :98-102

Eryavec G , Lilly S. Development of an inpatient geriatric psychiatry program in a community general hospital. Bulletin of the Canadian Academy of Geriatric Psychiatry 2002; 10(1); 10.

Fan, X. D., Li, X.-M . and Juorio, A.V. (2000) Substantia nigra reticulata lesion facilitates kainic acid-induced seizures. Brain Res 877, 107-109.

Fan, X. D., Li, X.-M . and Juorio, A.V. (2000) Substantia nigra par reticulata lesion induces preconvulsive behavior and changes in glutamate receptor gene expression in the rat brain. Brain Res 867, 40-51.

Fang, J., McKay, G., Remillard, A., Li, X.-M . and Midha K.K. (2001) In vitro characterization of the metabolism of haloperidol using recombinant cytochrome P450 enzymes and human liver microsomes. Drug Metab Disp 12:1-6.

Feinstein, A., and Rapoport, M. (2000). Mild traumatic brain injury:The silent epidemic. Canadian Journal of Public Health, 91(5), 325-326.

Feldman, H., Scheltens, P., Scarpini, E., Herrmann, N ., Mesenbrink, P., Mancione, L., Tekin, S., Lane, R., Ferris, S.:  Behavioral symptoms in mild cognitive impairment.  Neurology 62:1199-1201, 2004.

Flint AJ , Rifat SL. Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression. Depress Anxiety. 2001;13(3):125-31.

Flint A , Silveira J . Antidepressant use among elderly patients. Am J Psychiatry. 2001 Feb;158(2):328-30.

Flint AJ , Rifat SL. Maintenance treatment for recurrent depression in late life. A four-year outcome study. Am J Geriatr Psychiatry. 2000 Spring;8(2):112-6.

Groulx B. "Screaming and Wailing in Dementia Patients" Part I, The Canadian Alzheimer Disease Review, vol. 6, no. 2, pp.11-14; January 2004.

Groulx B . "Screaming and Wailing in Dementia Patients" Part II, The Canadian Alzheimer Disease Review, vol. 8, no. 1, pp. 7-11, January 2005.

Groulx B . "Management of Alzheimer's Disease: Assessing the Effects of Cholinesterase Inhibitors", The Canadian Journal of Diagnosis - vol. 20, no. 6, p. 49-52; June 2003.

Groulx B . "Changing therapeutic paradigms", in DEMENTIA, Edited by Mario Maj and Norman Sartorius, WPA Series - Evidence and Experience in Psychiatry, chapter 5.8, John Wiley and Sons Ltd 2000.

Groulx B . "Depression and dementia: what clinicians need to know" - The Canadian Alzheimer Disease Review, vol. 4, number 2, pp. 9-11; November 2000.

Groulx B . "Depression and dementia: what clinicians need to know - Part II"- The Canadian Alzheimer's Disease Review, vol. 4, no. 3, pp. 18-21; March 2001.

Groulx B . "Depression and Dementia: What Clinicians Need to Know - Part III" - The Canadian Alzheimer's Disease Review, vol. 4, no. 4, pp. 10-15; July 2001

Groulx, B. "La Maladie d'Alzheimer: de la tête au coeur", Les Éditions Publistar - Collection solution santé, 211 pages.

Glass, J.R., Sproule, B.A., Herrmann, N. Streiner, D., Busto, U.E.: Acute pharmacological effects of temazepam, diphenydramine and valerian in healthy elderly subjects.  Journal of Clinical Psychopharmacology, 23: 260-268, 2003.

Hall, J., Naranjo, C.A., Sproule, B.A., Herrmann, N . : Pharmacokinetic and pharmacodynamic evaluation of inhibition of alprazolam by citalopram and fluoxetine. Journal of Clinical Psychopharmacology, 23: 349-357, 2003.

Han L, Cole M , Bellavance F, McCusker J, Primeau F . Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis. Int Psychogeriatr. 2000 Jun;12(2):231-47.

Han L, McCusker J, Cole M , Abrahamowicz M, Primeau F , Elie M. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med. 2001 Apr 23; 161(8): 1099-105.

Hassan, P.C., Sproule, B.A., Naranjo, C.A., Herrmann, N .: Dose response evaluation of the interaction between sertraline and alprazolam in vivo. Journal of Clinical psychopharmacology. 20:150-158, 2000.

He, J., Xu, H., Yang, Y. and Li, X.-M . (2004). Neuroprotective effects of olanzapine on methamphetamine-induced neurotoxicity are associated with an inhibition of hyperthermia and prevention of Bcl-2 decrease in rats. Brain Res, 1018: 186-192.

Hébert, R., Dubois, M., Wolfson, C., Chambers, L., Cohen, C.A . (2001). Factors Associated with Long-term Institutionalization of Older People with Dementia. Journal of Gerontology: Medical Sciences (in press).

Herrmann, N ., Lanctôt, K.L., Khan, L.R.:  The role of norepinephrine in the behavioral and psychological symptoms of dementia.  Journal of Neuropsychiatry and Clinical Neurosciences 16:261-276, 2004.

Herrmann, N ., Knopman, D.:  Donepezil therapy for neuropsychiatric symptoms in AD: methods make the message.  Neurology 63:200-201, 2004

Herrmann, N .:  Geriatric psychiatry: a sub-specialty whose time has come.  Canadian Journal of Psychiatry 49:415-416, 2004.

Herrmann, N ., Lanctôt, K.L., Eryavec, G., van Reekum, R., Khan, L.: Growth hormone response to clonidine predicts aggression in Alzheimer's disease.  Psychoneuroendocrinology 29:1192-1197, 2004.

Herrmann, N ., Lanctôt, K.L., Eryavec, G., Khan, L.:  Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's Disease patients.  Journal of Psychopharmacology 18:215-220, 2004.

Herrmann, N ., Mamdani, M., Lanctôt, K.L.:  Atypical antipsychotics and the risk of stroke.  American Journal of Psychiatry, 161:1113-1115, 2004.

Herrmann, N. : Pharmacotherapy for Alzheimer's Disease. Current Opinion in Psychiatry, 15: 403-409, 2002.

Herrmann N . Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci. 2001 Feb;28 Suppl 1:S96-107.

Herrmann, N. , Black, S.E.: Behavioural disturbances in dementia. Neurology 55:1-2,2000. Herrmann N. Use of SSRIs in the elderly: obvious benefits but unappreciated risks. Can J Clin Pharmacol. 2000 Summer;7(2):91-5. Review.

Herrmann N , Lanctot K, Myszak M. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia. J Clin Psychopharmacol. 2000 Feb;20(1):90-3.

Herrmann, N ., Moosa, S.:  Benefits and risks of pharmacotherapy for behavioral disturbances in dementia: How does the balance tip?  Trends in Evidence-Based Neuropsychiatry, 6:47-53, 2004.

Hottin, Paule , L'insomnie chez la personne âgée , Le Médecin du Québec , Volume 36 , numéro 8, août 2001 .

Hottin, Paule , Place des nouveaux antipsychotiques en gériatrie , Volumes des actes du congrès scientifique : Vieillissement et problèmes de santé mentale , 157-168 , Edisem , 2004 .

Juurlink, D., Herrmann, N ., Szalai, J.P., Koppa, A., Redelmeier, D.A.:  Medical illness and the risk of suicide in the elderly.  Archives of Internal Medicine, 164:1179-1184, 2004.

Knott, V., Bradford, L., Dulude, L., Millar, A., Al-Wahhabi, F., Lau, T., Shea, C., Wiens, A. , Effects of Stimulus Modality and Response Mode on the P300 Event-Related Potential Differentiation of Young and Elderly Subjects.  In:  Clinical Electroencephalography, Vol 34, No.4, 182-190, (2003)

L C Kopala, S Tan, C Shea , R Vandorpe, W G Honer, Adrenoleukodystrophy associated with psychosis, Schizophrenia Research 45, 261- 265 (2001).

Lanctôt, K.L., Herrmann, N ., Nadkarni, N., Leibovitch, F.S., Caldwell, C., Black, S.E.:  Medial temporal hypoperfusion is associated with aggression in Alzheimer's Disease.  Archives of Neurology 61:1731-1737, 2004.

Lanctôt, K.L., Mazzotta, P., Khan, L., Ingber, N., Herrmann, N .: GABAergic function in Alzheimer's Disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioral and psychological symptoms of dementia.  Canadian Journal of Psychiatry 49:439-453, 2004.

Lanctôt, K.L., Herrmann, N ., Yau, K.K., Khan, L.R., Liu, B.A., LouLou, M.M., Einarson, T.R.: Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.  Canadian Medical Association Journal, 169(6): 557-564, 2003

Lanctôt, K.L., Herrmann, N ., Emerson, T.R.:  Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease (letter).  Canadian Medical Association Journal, 170: 1372-1373, 2004.

Lanctôt, K.L., Herrmann, N. , Eryavec, G. van Reekum, R ., Reedk, K., Naranjo, C.A.: Central serotonergic activity is related to the aggressive behaviours of Alzheimer's Disease. Neuropsychopharmacology, 27: 647-655, 2002.

Lanctot KL, Herrmann N . Donepezil for behavioural disorders associated with Lewy bodies: a case series. Int J Geriatr Psychiatry. 2000 Apr;15(4):338-45.

Lanctôt, K.L., Bowles, S.K., Herrmann, N ., Best, T., Naranjo, C.A.: Drugs mimicking dementia: Dementia symptoms associated with psychotropic drugs in institutionalized cognitively impaired patients. CNS Drugs 14:381-390, 2000.

Lanctôt, K.L., Herrmann, N., van Reekum, R., Eryavec, G. , Naranjo, C.A.: Gender, aggression and serotonergic function are associated with response to sertraline for behavioral disturbances in Alzheimer's disease. International Journal of Geriatric Psychiatry, 17: 531-541, 2002.

Lanctot KL, Herrmann N , Mazzotta P. Role of serotonin in the behavioral and psychological symptoms of dementia. J Neuropsychiatry Clin Neurosci. 2001 Winter;13(1):5-21. Review.

Leech DD, Taunton JE, Dalton A, Donnelly ML , Rhodes EC, Elliott J, Rhodes R, Martin AD. “Muscular Strength Changes in Women Ages 75-80 After Six Weeks of Resistance Training”. NZ J Sports Med 2000; 27(4).

Leveque, J.-C., Macías, W., Barczak, A., Kang, S., Li, X.-M. , Coyle, J.T., Huganir, R.L., Heckers, S. and Konradi, C. (2000) Intracellular modulation of NMDA receptor function by antipsychotic drugs. J. Neurosci, 20, 40114020.

Li., X.-M. , Chlan-Fourney, J., Bennett, V., Juorio, A.V. and Bowen, R. (2000) Antidepressants upregulate mRNA levels of the neuroprotective enzyme superoxide dismutase (SOD1). J Psychiat Neurosci 25, 43-47.

Li, X.-M. , Juorio, A.V., Bennett, V., Shrikhande, S. and Bowen, R. (2000) Antidepressants increase gene expression of a neuroprotective enzyme. Can J Psychiat 45, 296.

Lieff S . , (PA*), M. Andrew, R. Tiberius. Community Psychiatrists who see Geriatric Patients: What's training got to do with it? To be published in Academic Psychiatry, 28:1, Spring 2004

Lieff S . , (PA*), G. Warshaw, E. Bragg, R. Shaull, C. Lindsell, L. Goldenhar. Geriatric Psychiatry Fellowship Programs in the United States; Findings from the Association of Directors of Geriatric Academic Programs' Longitudinal Study of Training and Practice American Journal of Geriatric Psychiatry, June 2003, 11: 291-299

Lieff S . , (PA*), G. Tolomiczenko, L. Dunn. Effect of Training and Other Influences on The Development of Career Interest in Geriatric Psychiatry American Journal of Geriatric Psychiatry, June 2003, 11: 300-308

Lieff S . , (PA*). Balanced Living: Intertwining career, family and personal priorities. Academic Psychiatry, Fall 2003, 27: 3: 207-208

Lieff S . , (PA*), D. Clarke. Canadian Geriatric Psychiatrists: Why do they do it? A Delphi Study. Canadian Journal of Psychiatry, Vol. 47 (3), April 2002, 250-256.

Lieff SJ , Clarke D. What factors contribute to senior psychiatry residents' interest in geriatric psychiatry? a Delphi study. Can J Psychiatry. 2000 Dec; 45(10):912-6.

Luo, C., Xu, H.. and Li, X.-M . (2004). Post-stress changes in BDNF and Bcl-2 immunoreactivities in hippocampal neurons: effects of chronic administration of olanzapine. Brain Res, 1025:194-202.

McCourt P, Lockhart B, Donnelly M . Best Practices for the Mental Health of Older Adults . Writings in Gerontology, National Advisory Council on Aging. 2002 (18)

McGee P., Donnelly ML . “Factors Affecting the Mental health of Older Adults in Rural and Urban Communities: An Exploration”. Accepted for publication by the Canadian Journal of Community Mental Health 2004

Mohapel, P., Zhang, X., Gillespie, G., Chlan-Fourney, J., Hannesson, D.K., Corley, S.M., Li., X.-M. and Corcoran, M.E. (2001) Kindling of claustrum and insular cortex: comparison to pherirhinal cortex. Eur J Neurosci. 13, 1501-1519.

S. Montgomery; A.Beekman; J. Sadavoy ; C. Salzman; C. Thompson; S. Zisook. Discussion: Late-Life Depression: Prevalence and Presentation, Course, and Outcome. The Primary Companion to the J Clinical Psychiatry, 2(5): 7-8, 2000.

S. Montgomery, A.Beekman, J. Sadavoy , C. Salzman, C. Thompson, S. Zisook. Discussion: Depression and Medical Illness in Later Life. The Primary Companion to the J Clinical Psychiatry, 2(5): 15-16, 2000.

S. Montgomery, A.Beekman, J. Sadavoy , C. Salzman, C. Thompson, S. Zisook. Discussion: Diagnostic Issues in Depression of the Elderly. The Primary Companion to the J Clinical Psychiatry, 2(5): 23-24, 2000.

S. Montgomery, A.Beekman, J. Sadavoy ; C. Salzman, C. Thompson, S. Zisook. Discussion: Dementia and Bereavement: Adverse Life Experiences Complicating Depression in Later Life. The Primary Companion to the J Clinical Psychiatry, 2(5): 32, 2000

S. Montgomery; A.Beekman, J. Sadavoy , C. Salzman, C. Thompson, S. Zisook. Discussion: Management Considerations for Late-Life Depression, The Primary Companion to the J Clinical Psychiatry, 2(5) 37-38, 2000.

S. Montgomery, A.Beekman, J. Sadavoy , C. Salzman, C. Thompson, S. Zisook. Discussion: Therapy Choices for Late-Life Depression, The Primary Companion to the J Clinical Psychiatry, 2(5), 44-45, 2000.

Naranjo, C.A., Fourie, J., Herrmann, N. , Lanctôt, K.L., Birt, C., Yau, K.K.: Probing peripheral and central cholinergic system responses. Journal of Psychiatry and Neuroscience. 25:325-336, 2000.

up

Olders H . Average sunrise time predicts depression prevalence. J Psychosom Res 2003;55(2):99-105.

Olders H , Winningham ML. Select psychiatric and psychological considerations. In: Winningham ML, Barton-Burke M, eds. Fatigue in cancer: a multidimensional approach. Sudbury, MA: Jones & Bartlett, 2000:197-242.

Patterson, C., Cohen, C.A. , Hogan, D., (2000) Dementia Compendium of Pharmaceuticals and Specialties (CPS), Canadian Pharmacists Association, Ottawa, Canada

Pwee, K.H., Shukla, V.K., Herrmann, N . , Skidmore, B.: Novel antipsychotics for agitation in dementia: a systematic review. Canadian Coordinating Office for Health Technology Assessment (CCOHTA). March, 2003.

Qing, H., Xu, H., Wei, Z., Gibson, K. & Li, X.M . (2003). The ability of atypical antipsychotic drugs vs haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci 17:1563-1570.

Ramasubbu R, Flint A , Brown G, Awad G, Kennedy S. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.Psychoneuroendocrinology. 2000 Feb;25(2):139-50.

Rapoport, M. (2001). The cerebellum in psychiatric disorders.International Review of Psychiatry, 13, 295-301.

Rapoport, M. , and Feinstein, A. (2000). Outcome of traumatic braininjury in the elderly: A critical review. Brain Injury, 14(8), 749-761.

Rapoport, M. , and Feinstein, A. (2001). Age and functioning aftermild traumatic brain injury: The acute picture. Brain Injury, 15(10),857-864.

Rapoport, M. , Levin, H.S., McCauley, S.M., Song, J., Feinstein, A.(2002). The role of injury severity in neurobehavioral outcome 3 monthsfollowing traumatic brain injury. Neuropsychology, Neuropsychiatry, andBehavioral Neurology, 15, 123-132.

Rapoport, M. , McCullagh, S., Streiner, D., Feinstein, A. (In Press).Age and Major Depression following Mild Traumatic Brain Injury. AmericanJournal of Geriatric Psychiatry.

Rapoport, M. , McCullagh, S., Streiner, D., Feinstein, A. (In Press).The Clinical Significance of Major Depression Following Mild Traumatic BrainInjury. Psychosomatics.

Rapoport, M. , and vanReekum, R . (2000). Treating psychosis in dementia.In Ancill, R.J., Holliday, S.G., Thorpe, L., and Rabheru, K. (eds). Treating Dementia: Cognition and Beyond. Vancouver, B.C.: Canadian Academic Press.

Rapoport MJ , van Reekum R , Freedman M, Streiner D, Simard M, Clarke D, Cohen T, Conn D. Relationship of psychosis to aggression, apathy and function in dementia. Int J Geriatr Psychiatry. 2001 Feb;16(2):123-30.

Rapoport M, van Reekum R , Mayberg H. The role of the cerebellum in cognition and behavior: a selective review. J Neuropsychiatry Clin Neurosci. 2000 Spring;12(2):193-8. Review.

Reichenfeld HF - François: A True Story. Adbusters; 13; No1. Special Year End Issue; Jan/Feb 2005

Reichenfeld HF . , Pub therapy vindicated - The Nottingham 1980 Club, forerunner of the International Psychogeriatric Association. Bulletin International Psychogeriatric Association.;20;14-15; 2003

Reichenfeld HF , Agbayewa F - Geriatric psychiatry comes of age - the role of CPA. CPA Bulletin; 33; 21-22; 2001

Reichenfeld HF - Quality end-of-life care: the rights of every Canadian. A Point of View . Annals RCPSC.; (accepted for publication); 2001

Reichenfeld HF - The Birmingham Provident Dispensary Hockley Branch 1877-1948. A chapter in the development of community medical services. Birmingham Historian (accepted for publication); 2001

Remy F, Mirrashed F, Campbell B , Richter W. Mental Calculation Impairment in Alzheimer's Disease: a functional magnetic resonance imaging study. Neuroscience Letters 358(2004) 25-28.

Robillard M , Conn D. Lamotrigine Use in Geriatric Patients with Bipolar Depression. Canadian Journal of Psychiatry, 47(8),767-770,October 2002.

Robillard M . Geriatric Depression Scale. Journal of Geriatric Care. 1 (2) 171-173.

Robillard M., Conn D. Gabapentin Use in Geriatric Patients With Depression and Bipolar Illness; Canadian Journal of Psychiatry, 46(8),764,October 2001.

Robillard M ., Lieff S. Augmentation of Antidepressant Therapy by Buspirone: Three Geriatric Case Histories. Canadian Journal of Psychiatry, 40 (10) 639-640, December 1995.

Rockwood, D., Shea, C. , Behavioral and psychological symptoms in vascular dementia.  Chapter 9 in:  Vascular Cognitive Impairment: Preventable Dementia, ed. by John V. Bowler and Vladimir Hachinski, Oxford University Press, 110-125, (2003)

K Rockwood and C Shea ,; Therapeutic Choices, 3rd edition, Editor-in-chief, Jean Gray. Chapter 3 "Dementia", 25-32, Canadian Pharmacists Association, 2000

up

Sadavoy J , Diagnostic Issues in Depression of the Elderly. The Primary Companion to the J. Clinical Psychiatry, 2(5): 17-22, 2000.

Shulman KI . Clock-drawing: is it the ideal cognitive screening test?Int J Geriatr Psychiatry. 2000 Jun;15(6):548-61

Shulman, Kenneth I . and Walker, Scott E. (2001) A re-evaluation of dietary restrictions forirreversible monoamine oxidase inhibitors. Psychiatric Annals, 31(6), 378-384.

Shulman, Kenneth I . (In Press) The significance of manic syndromes in old age.Reviews in Clinical Gerontology.

Shulman, K.I. (2000) Anxiety, paranoid and manic disorders in Oxford Textbookof Geriatric Medicine (eds. Evans, G., Grimley, J., Beattie, B.L., Michel, J-P. andWilcock, G.K.). Oxford University Press, Oxford: 1000-1008.

Shulman, K.I. and Herrmann, N. (2000) Mania in old age: Implications for classification, pathogenesis and treatment in Bipolar Disorders: 100 years after manic-depressive insanity (eds. Marneros, A. and Angst, J.). Kluwer Academic Publishers, Great Britain: 153-174.

Shulman, K.I. (2000) Commentary on Dementia: Disease definition, natural history and epidemiology in Evidence and Experience in Psychiatry (eds: Maj. M. and Sartorius, N.). John Wiley & Sons, Chichester: Volume 3, 55-57.

Kusumaker, V., Kutcher, S. and Shulman, K.I. (In Press) Diagnosis and treatment of bipolar disorder in young people and the elderly in Bipolar Disorder: A Clinician's Guide to Biological Treatments (eds: Yatham, L.N., Kusumakar, V. and Kutcher, S.).

Shulman, K.I. and Herrmann, N. (In Press) Manic syndromes in old age in Psychiatryin the Elderly - Third Edition (eds: Jacoby, R. and Oppenheimer, C.). Oxford UniversityPress, Oxford.

Shulman, K.I. , Schaffer, A., Levitt, A. and Herrmann, N. (In Press) Effects of gender and age on phenomenology and management in WPA Series "Evidence & Experience in Psychiatry: Bipolar Disorder" (ed: Maj. M.). John Wiley & Sons Ltd, Chichester, England.

Shulman RW , Faierman-Shulman CA. Elder Financial Abuse: A review for primary care physicians. The Canadian Alzheimer Disease Review 2000; 4(1):8-11.

Shulman RW, Olanzapine Taken with Dinner Keeps Drowsiness at Bay. Geriatrics & Aging, December 2000.

Shulman RW , Elderly Woman with Dementia & Agitation: A Diagnostic and Therapeutic Dilemma. Geriatrics & Aging, January/February 2001.

Simard M, van Reekum R . Dementia with Lewy bodies in Down's syndrome.Int J Geriatr Psychiatry. 2001 Mar;16(3):311-20. Review.

Simard M, van Reekum R , Cohen T. A review of the cognitive and behavioral symptoms in dementia with Lewy bodies. J Neuropsychiatry Clin Neurosci. 2000 Fall;12(4):425-50. Review.

Singh A, Black SE, Herrmann N , Leibovitch FS, Ebert PL, Lawrence J, Szalai JP. Functional and neuroanatomic correlations in poststroke depression: theSunnybrook Stroke Study. Stroke. 2000 Mar;31(3):637-44.

Sourial R, McCusker J, Cole M , Abrahamowicz M. Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden. Int Psychogeriatr. 2001 Jun;13(2):183-97.

Sproule BA, Hardy BG, Shulman KI . Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000 Mar;16(3):165-77.

Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging. 2000 Mar;16(3):165-77.

Stergiopoulos, V., Herrmann, N. : Old and homeless: a growing population. Canadian Journal of Psychiatry, 48: 374-380, 2003.

Taunton JE, Rhodes E., Donnelly M , Elliott J. “The effects of progressive resistance training on body composition, muscular strength, bone mineral density, functional ability and psychological attitudes of women 75-80 years” NZ Journal of Sports Medicine , 2003, 30;4:106-111

Thompson, S., Lanctôt, K.L., Herrmann, N .:  The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert Opinion in Drug Safety 3(5):425-440, 2004.

Thorpe L, Groulx B. Treatment of depressive syndromes in dementia. Chapterin Treating Dementia: Cognition and Beyond, Edited by RJ Ancill, SGHolliday, K Rabheru, and L Thorpe, 2000 Canadian Academic Press.

Thorpe L , Whitney D, Kutcher S, Kennedy S, and the CANMAT Depression Working Group. Clinical Guidelines for the treatment of depression. VI. Specialpopulations. Can J Psychiatry 2001; 26 June(Supp): 63S-76s

Thorpe L, Groulx B. Depressive syndromes in dementia. Canadian Journal ofNeurological Sciences 2001;28: Supp 1:S83-S95

Thorpe L , Middleton J, Russell G, Stewart N. Bright light therapy for demented nursing home patients with behavioral disturbance. American Journal of Alzheimer Disease 2000;15(1):18-26

Thorpe L . Dementia in Adults with Intellectual Disabilities: Assessment andManagement. Canadian Alzheimer Review November 2000: 18-21

Tierney, M., Herrmann, N. , Geslani, D., Szalai, J.P.: Contribution of informant and patient ratings to the accuracy of the mini-mental state examination in predicting probable Alzheimer's disease. Journal of the American Geriatric Society, 51: 813-818, 2003.

Tremblay, L.K., Naranjo, C.A., Cardenas, L. Herrmann, N ., Busto, U.E.: Probing the brain reward system in major depressive disorder: altered response to d-amphetamine. Archives of General Psychiatry, 59: 409-416, 2002.

van Reekum R , Streiner DL, Conn DK. Applying bradford hill's criteria for causation to neuropsychiatry: challenges and opportunities. J Neuropsychiatry Clin Neurosci. 2001 Summer;13(3):318-25.

van Reekum R , Cohen T, Wong J. Can traumatic brain injury cause psychiatric disorders? J Neuropsychiatry Clin Neurosci. 2000 Summer;12(3):316-27

van Reekum R , Simard M, Clarke D, Conn D , Cohen T, Wong J. The role of depression severity in the cognitive functioning of elderly subjects with central nervous system disease. J Psychiatry Neurosci. 2000 May;25(3):262-8

Wei, Z., Bai, O., Richardson, J.S., Mousseau, D.D. & Li, X.M . (2003). Olanzapine Protects PC12 Cells from Oxidative Stress Induced by Hydrogen Peroxide. J Neurosci Res 73:364-368.

Wei, Z., Mousseau, D.D., Richardson, J.S., Dyck, L.E. and Li, X.-M . (2003). Atypical antipsychotics attenuate neurotoxicity of b -amyloid (25-35) by modulating Bax and Bcl- X L/S expression and localization. J Neurosci. Res . 74:942-947.

Wentzell, K Rockwood, C McKnight, C Shea , S Darvish; Inter-rater Reliability of the Diagnosis of Vascular Cognitive Impairment at a Memory Clinic, Neuroepidemiology, 2000; 19: 186-193.

Wiens A. How does grapefruit juice affect psychotropic medications?. Journal of Psychiatry and Neuroscience. 25(2): 198, Mar 2000 C.

Wu, G., Lanctôt, K.L, Herrmann, N . , Moosa, S., Oh, P.I..: The cost-benefit of cholinesterase inhibitors in mild to moderate dementia – a willingness to pay approach. CNS Drugs, 17: 1-13, 2003.

Xu, H., He, J., Richardson, J.S. and Li, X.-M . (2004). The response of synaptophysin and microtubule-associated protein 1 to restraint stress in rat hippocampus and its modulation by venlafaxine. J Neurochem, 91: 1380-8 .

Xu, H., Richardson, J.S., Luo, C. and Li, X.-M . (2004). The recovery of hippocampal neurogenesis and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine. Pharmacogenomics J , 4, 322–331

Xu, H., Richardson, J.S., and Li, X-M . (2003). Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, Bcl-2, and Cu/Zn-SOD in rat hippocampus. Neuropsychopharmacology 28:53-62 .

Xu, H., Qing, H., Lu, W., Keegan, D., Richardson, J., Chlan-Fourney, J. and Li, X.-M . (2002). Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expresion in rat hipporcampus. Neurosci Lett 321:65-68.

 
 

TEL: (416) 921-5443 | 1-877-330-5443 | FAX (416) 967-6320
info@cagp.ca | www.cagp.ca
55 St. Clair Avenue West, Suite 255, Toronto, ON  M4V 2Y7